长治地区乙肝相关疾病直接经济负担及其影响因素分析  

Analysis on the direct economic burden and influencing factors of Hepatitis B-related diseases in Changzhi

作　　者：段培芬[1] 史武杰[1] 郭崇政[1] 张顺祥[2] 冯向先[1] 

机构地区：[1]山西省长治医学院预防医学系,山西长治046000 [2]深圳市疾病预防控制中心,广东深圳518073

出　　处：《现代预防医学》2015年第3期461-464,共4页Modern Preventive Medicine

基　　金："十一五"国家科技重大专项(2008ZX10002-001)

摘　　要：目的了解长治地区乙肝相关疾病直接经济负担及其影响因素。方法对住院患者采用面对面深度访谈的方式进行调查,采用多元逐步回归分析乙肝相关疾病直接经济负担的影响因素,使用SPSS16.0进行统计分析。结果乙肝相关疾病直接经济负担为17 462.01元,其中直接医疗费用和直接非医疗费用分别为15 978.30元和1 483.71元,各类乙肝相关疾病的直接医疗费用均大于直接非医疗费用;直接经济负担占家庭收入和人均收入的比重以原发性肝癌最高,分别为1.32和5.82倍;年龄、全家月均收入、是否使用抗病毒药、有无自购药品是其主要影响因素。结论长治地区乙肝相关疾病患者直接经济负担沉重,降低住院费用,控制药品费用,有效预防和控制病毒性感染,可缓解乙肝患者直接经济负担。Objective To estimate the direct economic burden of patients with HBV-related diseases and its relevant factors in Changzhi. Methods Patients were face-to-face investigated by questionnaires. Multiple linear stepwise regression was conducted to explore the factors linked to the direct economic burden. All of the data were analyzed by SPSS16.0. Results The annual direct cost per patient with HBV-related diseases was 17462.01 Yuan. The direct medical cost and direct non-medical cost was 15978.30 Yuan, 1483.71 Yuan, respectively. The direct medical cost were higher than the direct non-medical one. The influencing factors were age, personal income, buying drugs and use of antiviral drugs. Conclusion The direct economic burden of HBV-related diseases was significant for patients in Changzhi. Reducing hospitalization expenses, controlling the cost of drug and the infection of HBV may reduce the direct economic cost.

关 键 词：乙肝相关疾病 直接经济负担 影响因素 

分 类 号：R194[医药卫生—卫生事业管理]